1. Home
  2. SABS vs LWAY Comparison

SABS vs LWAY Comparison

Compare SABS & LWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SAB Biotherapeutics Inc.

SABS

SAB Biotherapeutics Inc.

HOLD

Current Price

$3.51

Market Cap

344.8M

Sector

Health Care

ML Signal

HOLD

LWAY

Lifeway Foods Inc.

HOLD

Current Price

$24.53

Market Cap

377.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
SABS
LWAY
Founded
2014
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Packaged Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
344.8M
377.8M
IPO Year
2020
1995

Fundamental Metrics

Financial Performance
Metric
SABS
LWAY
Price
$3.51
$24.53
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
2
Target Price
$10.75
$34.50
AVG Volume (30 Days)
260.5K
84.7K
Earning Date
05-12-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
78.53
48.33
EPS
N/A
0.31
Revenue
N/A
$103,350,000.00
Revenue This Year
N/A
$16.64
Revenue Next Year
N/A
$17.28
P/E Ratio
N/A
$76.74
Revenue Growth
N/A
N/A
52 Week Low
$1.85
$17.31
52 Week High
$5.15
$32.71

Technical Indicators

Market Signals
Indicator
SABS
LWAY
Relative Strength Index (RSI) 45.42 35.09
Support Level $3.39 $22.65
Resistance Level $4.02 $25.66
Average True Range (ATR) 0.12 0.79
MACD -0.02 -0.01
Stochastic Oscillator 44.79 15.55

Price Performance

Historical Comparison
SABS
LWAY

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical-stage biopharmaceutical company focused on developing multi-specific, high-potency, human immunoglobulin G (hIgG) to treat and prevent immune and autoimmune disorders. The company's lead product candidate, SAB-142, targets autoimmune Type 1 Diabetes (T1D) with a disease-modifying therapeutic approach that aims to change the T1D treatment paradigm by delaying onset and potentially preventing disease progression of Stage 3 T1D patients. It is focused on developing product candidates for disease targets where a differentiated approach has the greatest potential to be either first-in-class against novel targets against complex targets to treat diseases, including type 1 diabetes (T1D) and other autoimmune disorders.

About LWAY Lifeway Foods Inc.

Lifeway Foods Inc is engaged in manufacturing probiotic, cultured, functional dairy health food products. Its primary product is drinkable kefir, which is a cultured dairy product. Its product categories are Drinkable Kefir, which is the key revenue-driving product, European-style soft cheeses, Cream, ProBugs, Frozen Kefir, and Other dairy. The company manufactures and markets products under the Lifeway and Fresh Made brand names, as well as under private labels on behalf of customers. It sells the products through a direct sales force, brokers, and distributors.

Share on Social Networks: